Technical Analysis for ENLV - Enlivex Therapeutics Ltd.

Grade Last Price % Change Price Change
B 4.18 1.70% 0.07
ENLV closed up 1.7 percent on Monday, March 18, 2024, on 1.18 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Apr 1
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Calm After Storm Range Contraction 1.70%
NR7 Range Contraction 1.70%
Narrow Range Bar Range Contraction 1.70%
Upper Bollinger Band Walk Strength 1.70%
Inside Day Range Contraction 1.70%
Wide Bands Range Expansion 1.70%
Overbought Stochastic Strength 1.70%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 7 hours ago
Rose Above Previous Day's High about 7 hours ago
Outside Day about 7 hours ago
Up 3% about 7 hours ago
Up 2% about 7 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatment Tumor Virotherapy Coronavirus Cytokine Inflammatory Conditions Cytokine Release Syndrome

Is ENLV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.37
52 Week Low 1.2
Average Volume 77,371
200-Day Moving Average 2.38
50-Day Moving Average 3.14
20-Day Moving Average 3.49
10-Day Moving Average 3.85
Average True Range 0.34
RSI (14) 66.78
ADX 33.1
+DI 23.24
-DI 13.92
Chandelier Exit (Long, 3 ATRs) 3.34
Chandelier Exit (Short, 3 ATRs) 3.81
Upper Bollinger Bands 4.41
Lower Bollinger Band 2.58
Percent B (%b) 0.88
BandWidth 52.41
MACD Line 0.33
MACD Signal Line 0.25
MACD Histogram 0.076
Fundamentals Value
Market Cap 77.74 Million
Num Shares 18.6 Million
EPS -1.47
Price-to-Earnings (P/E) Ratio -2.84
Price-to-Sales 0.00
Price-to-Book 1.35
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.66
Resistance 3 (R3) 4.64 4.45 4.58
Resistance 2 (R2) 4.45 4.33 4.47 4.55
Resistance 1 (R1) 4.32 4.26 4.23 4.34 4.53
Pivot Point 4.13 4.13 4.09 4.15 4.13
Support 1 (S1) 4.00 4.01 3.91 4.02 3.83
Support 2 (S2) 3.81 3.94 3.83 3.81
Support 3 (S3) 3.68 3.81 3.78
Support 4 (S4) 3.70